Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Sebti

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Biochemistry|July 14, 1987
Purification, characterization, and amino acid composition of rabbit pulmonary bleomycin hydrolaseS M Sebti, J C DeLeon, J S Lazo
Anti-Cancer Drug Design|June 1, 1997
Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug designE C Lerner, A D Hamilton, S M Sebti
Cancer Research|April 1, 1985
Species- and length of exposure-dependent differences in the benzo(a)pyrene:DNA adducts formed in embryo cell cultures from mice, rats, and hamstersS M Sebti, D Pruess-Schwartz, W M Baird
Oncogene|October 20, 2001
Ras and RhoA suppress whereas RhoB enhances cytokine-induced transcription of nitric oxide synthase-2 in human normal liver AKN-1 cells and lung cancer A-549 cellsF L Delarue, B S Taylor, S M Sebti
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
BleomycinJ S Lazo, S M Sebti, J H Schellens
Cancer Communications|May 1, 1991
Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude miceS M Sebti, G T Tkalcevic, J P Jani
Journal of Chromatography|August 10, 1990
Separation of bleomycins and their deamido metabolites by high-performance cation-exchange chromatographyJ S Mistry, S M Sebti, J S Lazo
Environmental Health Perspectives|September 1, 1986
Metabolic activation of benzo(a)pyrene in SENCAR and BALB/c mouse embryo cell culturesW M Baird, S M Sebti, L A Reinsvold
Oncogene|April 3, 1998
Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenograftsJ Sun, Y Qian, A D Hamilton, et al.
Journal of Medicinal Chemistry|January 5, 1996
Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitorsY Qian, A Vogt, S M Sebti, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Biochemistry|July 14, 1987
Purification, characterization, and amino acid composition of rabbit pulmonary bleomycin hydrolaseS M Sebti, J C DeLeon, J S Lazo
Anti-Cancer Drug Design|June 1, 1997
Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug designE C Lerner, A D Hamilton, S M Sebti
Cancer Research|April 1, 1985
Species- and length of exposure-dependent differences in the benzo(a)pyrene:DNA adducts formed in embryo cell cultures from mice, rats, and hamstersS M Sebti, D Pruess-Schwartz, W M Baird
Oncogene|October 20, 2001
Ras and RhoA suppress whereas RhoB enhances cytokine-induced transcription of nitric oxide synthase-2 in human normal liver AKN-1 cells and lung cancer A-549 cellsF L Delarue, B S Taylor, S M Sebti
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
BleomycinJ S Lazo, S M Sebti, J H Schellens
Cancer Communications|May 1, 1991
Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude miceS M Sebti, G T Tkalcevic, J P Jani
Journal of Chromatography|August 10, 1990
Separation of bleomycins and their deamido metabolites by high-performance cation-exchange chromatographyJ S Mistry, S M Sebti, J S Lazo
Environmental Health Perspectives|September 1, 1986
Metabolic activation of benzo(a)pyrene in SENCAR and BALB/c mouse embryo cell culturesW M Baird, S M Sebti, L A Reinsvold
Oncogene|April 3, 1998
Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenograftsJ Sun, Y Qian, A D Hamilton, et al.
Journal of Medicinal Chemistry|January 5, 1996
Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitorsY Qian, A Vogt, S M Sebti, et al.
Pageof 11